1-4 of 4
feverfew
Close
Sort by
Journal Articles

Analysis of the Anti-Leukemia Mechanism of Parthenolide.

ShanShan Pei, Monica L. Guzman, PhD, Shama Nasim, Lei Shi, Peter A Crooks, PhD, Craig T. Jordan, PhD
Journal: Blood
Blood (2009) 114 (22): 2734.
https://doi.org/10.1182/blood.V114.22.2734.2734
Published: 2009
Journal Articles

Level of Myeloperoxidase Expression as a Crucial Determinant of Sensitivity of Myeloid Leukemia Cells to Parthenolide-Induced Apoptosis

Soo Jeong Kim, M.D., Ju In Eom, Hye Won Lee, M.D., Hoi Kyung Jeung, Jin Seok Kim, M.D., Ph.D., Yoo-Hong Min, M.D., Ph.D.
Journal: Blood
Blood (2008) 112 (11): 2945.
https://doi.org/10.1182/blood.V112.11.2945.2945
Published: 2008
Journal Articles

A Novel Orally Available Parthenolide Analog Selectively Eradicates AML Stem and Progenitor Cells.

Monica L. Guzman, PhD, Randall M. Rossi, MS, Xiaojie Li, BS, Cheryl Corbett, BS, Duane C. Hassane, PhD, Timothy Bushnell, PhD, Martin Carroll, MD, Edmund Sullivan, DVM, Sundar Neelakantan, PhD, Peter A. Crooks, PhD, Craig T. Jordan, PhD
Journal: Blood
Blood (2006) 108 (11): 237.
https://doi.org/10.1182/blood.V108.11.237.237
Published: 2006
Journal Articles

Selective Induction of Apoptosis in Acute Myelogenous Leukemia Stem Cells by the Novel Agent Parthenolide.

Monica L. Guzman, PhD, Lilliana Karnischky, Xiaojie Li, Sarah J. Neering, MS, Randal M. Rossi, Craig T. Jordan, PhD
Journal: Blood
Blood (2004) 104 (11): 2542.
https://doi.org/10.1182/blood.V104.11.2542.2542
Published: 2004